74 related articles for article (PubMed ID: 2032216)
1. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
Mujoo K; Rosenblum MG; Murray JL
Cancer Res; 1991 Jun; 51(11):2768-72. PubMed ID: 2032216
[TBL] [Abstract][Full Text] [Related]
2. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
5. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
[TBL] [Abstract][Full Text] [Related]
6. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
7. Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate.
Murray JL; Mujoo K; Wilmanns C; Mansfield P; Wilbur DS; Rosenblum MG
J Nucl Med; 1991 Feb; 32(2):279-87. PubMed ID: 1992032
[TBL] [Abstract][Full Text] [Related]
8. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
[TBL] [Abstract][Full Text] [Related]
10. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract][Full Text] [Related]
11. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
12. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines.
Matzku S; Bröcker EB; Brüggen J; Dippold WG; Tilgen W
Cancer Res; 1986 Aug; 46(8):3848-54. PubMed ID: 3731060
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
14. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
15. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
16. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
Lindmo T; Boven E; Mitchell JB; Morstyn G; Bunn PA
Cancer Res; 1985 Oct; 45(10):5080-7. PubMed ID: 4027987
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
18. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
